Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 4
1971 1
1972 10
1973 8
1974 10
1975 13
1976 8
1977 14
1978 6
1979 14
1980 14
1981 22
1982 30
1983 24
1984 24
1985 30
1986 24
1987 25
1988 37
1989 33
1990 35
1991 40
1992 25
1993 26
1994 28
1995 24
1996 24
1997 28
1998 14
1999 12
2000 21
2001 25
2002 16
2003 22
2004 23
2005 26
2006 23
2007 22
2008 18
2009 20
2010 13
2011 29
2012 38
2013 21
2014 16
2015 22
2016 23
2017 25
2018 14
2019 7
2020 9
2021 15
2022 15
2023 10
2024 16
2025 10
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,056 results

Results by year

Filters applied: . Clear all
Page 1
Effects of clindamycin and amoxycillin as prophylaxis against early implant failure: double-blinded randomized clinical trial.
Pradillo-Gallego D, Manzano-Moreno FJ, Ocaña-Peinado FM, Olmedo-Gaya MV. Pradillo-Gallego D, et al. Clin Oral Investig. 2024 Nov 16;28(12):643. doi: 10.1007/s00784-024-06050-1. Clin Oral Investig. 2024. PMID: 39548015 Clinical Trial.
CONCLUSIONS: A single dose of 600 mg clindamycin before implant surgery does not increase the risk of early implant failure or infection. CLINICAL RELEVANCE: These findings suggest that a single dose of 600 mg clindamycin at 1 h before implant surgery is a safe anti …
CONCLUSIONS: A single dose of 600 mg clindamycin before implant surgery does not increase the risk of early implant failure or infect …
Clindamycin Phosphate 1.2%/Adapalene 0.15%/ Benzoyl Peroxide 3.1% for Acne: Results From A 6-Month Open-Label Study.
Draelos ZD, Ghannoum M, Stein Gold L, Harper JC, Baldwin H, Guenin E, Tanghetti EA. Draelos ZD, et al. J Drugs Dermatol. 2025 May 1;24(5):516-523. doi: 10.36849/JDD.9018. J Drugs Dermatol. 2025. PMID: 40327582 Clinical Trial.
In 12-week clinical trials, triple-combination clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel (CAB) demonstrated efficacy and tolerability in the treatment of moderate to severe acne. ...  Citation: Draelos ZD, Ghannoum M, Stein Gold L, et al …
In 12-week clinical trials, triple-combination clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel (CAB) demonstrate …
Taste of Clindamycin and Acetaminophen.
Hashiba KA, Wo SR, Yamamoto LG. Hashiba KA, et al. Clin Pediatr (Phila). 2017 Feb;56(2):146-149. doi: 10.1177/0009922816657151. Epub 2016 Jul 19. Clin Pediatr (Phila). 2017. PMID: 27369430 Clinical Trial.
This study evaluated the taste palatability of liquid clindamycin and acetaminophen products on the market. Subjects rated the palatability of 3 clindamycin suspensions, 1 amoxicillin suspension (tasted twice), an acetaminophen elixir, and an acetaminophen suspensio …
This study evaluated the taste palatability of liquid clindamycin and acetaminophen products on the market. Subjects rated the palata …
The effect of preoperative clindamycin in reducing early oral implant failure: a randomised placebo-controlled clinical trial.
Santamaría Arrieta G, Rodríguez Sánchez F, Rodriguez-Andrés C, Barbier L, Arteagoitia I. Santamaría Arrieta G, et al. Clin Oral Investig. 2023 Mar;27(3):1113-1122. doi: 10.1007/s00784-022-04701-9. Epub 2022 Sep 13. Clin Oral Investig. 2023. PMID: 36098814 Free PMC article. Clinical Trial.
Furthermore, we calculated the number required to treat or harm (NNT/NNH). RESULTS: Both the control group and clindamycin group had 31 patients each. Two implant failures occurred in the clindamycin group (NNH = 15, p = 0.246). ...One clindamycin-treated pat …
Furthermore, we calculated the number required to treat or harm (NNT/NNH). RESULTS: Both the control group and clindamycin group had …
Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial.
Maiti R, Sirka CS, Ashique Rahman MA, Srinivasan A, Parida S, Hota D. Maiti R, et al. Clin Drug Investig. 2017 Nov;37(11):1083-1091. doi: 10.1007/s40261-017-0568-2. Clin Drug Investig. 2017. PMID: 28913735 Clinical Trial.
After randomization one group (n = 30) received tazarotene 0.1% plus clindamycin 1% gel and another group (n = 30) received adapalene 0.1% plus clindamycin 1% gel for 1 month. ...The ISGA score improved in 17 patients in the tazarotene plus clindamycin group …
After randomization one group (n = 30) received tazarotene 0.1% plus clindamycin 1% gel and another group (n = 30) received adapalene …
CABTREO(TM) (Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide) Topical Gel.
Gupta AK, Mann A, Vincent K, Abramovits W. Gupta AK, et al. Skinmed. 2024 Oct 22;22(5):375-378. eCollection 2024. Skinmed. 2024. PMID: 39433524 Clinical Trial.
Cabtreo(TM) (1.2% clindamycin phosphate, 0.15% adapalene, and 3.1% benzoyl peroxide) or IDP-126 topical gel was approved by the US Food and Drug Administration (FDA) in October 2023 for the treatment of moderate to severe acne vulgaris in patients aged 12 years. ...
Cabtreo(TM) (1.2% clindamycin phosphate, 0.15% adapalene, and 3.1% benzoyl peroxide) or IDP-126 topical gel was approved by the US Fo …
Comparative efficacy of probiotic yoghurt and clindamycin in treatment of bacterial vaginosis in pregnant women: a randomized clinical trial.
Hantoushzadeh S, Golshahi F, Javadian P, Khazardoost S, Aram S, Hashemi S, Mirarmandehi B, Borna S. Hantoushzadeh S, et al. J Matern Fetal Neonatal Med. 2012 Jul;25(7):1021-4. doi: 10.3109/14767058.2011.614654. Epub 2011 Oct 1. J Matern Fetal Neonatal Med. 2012. PMID: 21854132 Clinical Trial.
The patients were randomly assigned to receive either probiotic yoghurt (100 g twice a day/week) or orally administered clindamycin (300 mg twice a day/week). RESULTS: Ten patients in probiotic group and 9 subjects in clindamycin group had symptom recurrence (p > …
The patients were randomly assigned to receive either probiotic yoghurt (100 g twice a day/week) or orally administered clindamycin ( …
Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial.
Paavonen J, Mangioni C, Martin MA, Wajszczuk CP. Paavonen J, et al. Obstet Gynecol. 2000 Aug;96(2):256-60. doi: 10.1016/s0029-7844(00)00902-9. Obstet Gynecol. 2000. PMID: 10908773 Clinical Trial.
OBJECTIVE: To compare the efficacy and safety of clindamycin vaginal ovules with oral metronidazole for treatment of bacterial vaginosis. ...Of those, 77 (68.1%) of 113 patients were cured with clindamycin, compared with 80 (66. 7%) of 120 who were cured with metron …
OBJECTIVE: To compare the efficacy and safety of clindamycin vaginal ovules with oral metronidazole for treatment of bacterial vagino …
Plasma concentration of orally administered amoxicillin and clindamycin in patients receiving haemodialysis.
Solli CN, Bock M, Kaur KP, Kristensen JH, Greibe E, Hansen HP, Boesby L, Borg R, Chaudry M, Hoffmann-Lücke E, Moser C, Falkentoft AC, Fosbøl E, Østergaard L, Torp-Pedersen C, Bundgaard H, Iversen K, Bruun NE. Solli CN, et al. J Antimicrob Chemother. 2023 Mar 2;78(3):724-731. doi: 10.1093/jac/dkad002. J Antimicrob Chemother. 2023. PMID: 36640129 Free PMC article. Clinical Trial.
This study aims to determine if the plasma concentration of amoxicillin and clindamycin is sufficient during HD after oral administration of amoxicillin and clindamycin at three different time intervals prior to the HD procedure. ...A lower threshold was set at 2.0 …
This study aims to determine if the plasma concentration of amoxicillin and clindamycin is sufficient during HD after oral administra …
A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation.
Schachner L, Pestana A, Kittles C. Schachner L, et al. J Am Acad Dermatol. 1990 Mar;22(3):489-95. doi: 10.1016/0190-9622(90)70069-t. J Am Acad Dermatol. 1990. PMID: 2138180 Free article. Clinical Trial.
One hundred three patients with acne vulgaris were randomly designated to receive either a topical formulation of erythromycin plus zinc or a topical solution of 1% clindamycin phosphate (Cleocin-T). The patients treated themselves twice daily and were examined at 3, 6, 9, …
One hundred three patients with acne vulgaris were randomly designated to receive either a topical formulation of erythromycin plus zinc or …
1,056 results